Lori Panther | Sr. Director, Clinical Development, Infectious Diseases
Moderna Therapeutics

Lori Panther, Sr. Director, Clinical Development, Infectious Diseases, Moderna Therapeutics

Lori Panther, MD, MPH is Senior Director of Clinical Development, Infectious Diseases at Moderna, Inc., based in Cambridge, MA, USA. Dr. Panther is the Clinical Lead for Moderna’s investigational cytomegalovirus (CMV) vaccine program.

Prior to joining Moderna in 2016, Dr. Panther was Assistant Professor of Medicine at Harvard Medical School and Associate Director for Clinical Research of the Fenway Institute at Beth Israel Deaconess Medical Center in Boston, MA, where she directed NIH- and industry-sponsored early- and late-phase vaccine trials and interventional trials of modalities to prevent sexually transmitted infections.

Dr. Panther completed her Internal Medicine residency and chief residency at University of California, San Francisco, CA, USA; her Infectious Diseases fellowship at University of Washington, Seattle, WA, USA; and her Master of Public Health degree at the Harvard School of Public Health, Boston, MA, USA.


Day 2, April 8 @ 12:40

Showcase 5 - A Messenger RNA (mRNA) Vaccine Against Cytomegalovirus (CMV) Infection: Phase 1 Interim Data

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates